Feb 13 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2025 Dec 31, 2024 Dec 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 128 mln 257 mln
(-50.3 pct) (+773.3 pct)
Operating loss 941 mln loss 793 mln
Recurring loss 937 mln loss 755 mln
Net
Net loss 937 mln loss 806 mln
EPS loss 17.44 yen loss 18.56 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Medrx.Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T